Dumont & Blake Investment Advisors’s GEOPHARMA INC GORX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-40,000
| Closed | – | – | 209 |
|
|
2023
Q4 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 199 |
|
|
2023
Q3 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 191 |
|
|
2023
Q2 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 196 |
|
|
2023
Q1 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 194 |
|
|
2022
Q4 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 193 |
|
|
2022
Q3 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 201 |
|
|
2022
Q2 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 215 |
|
|
2022
Q1 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 227 |
|
|
2021
Q4 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 211 |
|
|
2021
Q3 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 211 |
|
|
2021
Q2 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 206 |
|
|
2021
Q1 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 208 |
|
|
2020
Q4 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 200 |
|
|
2020
Q3 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 189 |
|
|
2020
Q2 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 184 |
|
|
2020
Q1 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 198 |
|
|
2019
Q4 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 185 |
|
|
2019
Q3 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 191 |
|
|
2019
Q2 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 195 |
|
|
2019
Q1 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 192 |
|
|
2018
Q4 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 194 |
|
|
2018
Q3 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 193 |
|
|
2018
Q2 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 196 |
|
|
2018
Q1 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 205 |
|
|
2017
Q4 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 210 |
|
|
2017
Q3 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 202 |
|
|
2017
Q2 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 197 |
|
|
2017
Q1 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 196 |
|
|
2016
Q4 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 194 |
|
|
2016
Q3 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 193 |
|
|
2016
Q2 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 195 |
|
|
2016
Q1 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 189 |
|
|
2015
Q4 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 183 |
|
|
2015
Q3 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 179 |
|
|
2015
Q2 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 174 |
|
|
2015
Q1 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 174 |
|
|
2014
Q4 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 165 |
|
|
2014
Q3 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 164 |
|
|
2014
Q2 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 158 |
|
|
2014
Q1 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 157 |
|
|
2013
Q4 | $1K | Hold |
40,000
| – | – | ﹤0.01% | 149 |
|
|
2013
Q3 | $1K | Hold |
40,000
| – | – | ﹤0.01% | 147 |
|
|
2013
Q2 | $0 | Buy |
+40,000
| New | – | ﹤0.01% | 125 |
|
Dumont & Blake Investment Advisors's GORX Position: Q1 2024 in Review
Dumont & Blake Investment Advisors sold out of GEOPHARMA INC (GORX) in Q1 2024, closing a stake of 40,000 shares.
Dumont & Blake Investment Advisors first reported a position in GORX in Q2 2013 and held it in 43 quarters. The position peaked at $1K in Q4 2013. 0 funds tracked by Wall St. Rank hold GORX as of Q1 2024.
- Dumont & Blake Investment Advisors reported no remaining GEOPHARMA INC position as of Q1 2024 after selling out during the quarter.
- Dumont & Blake Investment Advisors sold 40,000 GEOPHARMA INC shares in Q1 2024.
- Dumont & Blake Investment Advisors first reported a position in GEOPHARMA INC in Q2 2013 and held it in 43 quarters.
- Dumont & Blake Investment Advisors's GEOPHARMA INC position peaked at $1K in Q4 2013.
- 0 funds tracked by Wall St. Rank held GEOPHARMA INC as of Q1 2024.
Based on Dumont & Blake Investment Advisors's 13F filing for Q1 2024, filed 17 Apr 2024.